Cargando…
A pharmacogenetics study to predict outcome in patients receiving anti-VEGF therapy in age related macular degeneration
PURPOSE: To ascertain whether single nucleotide polymorphisms (SNPs) in the Vascular Endothelial Growth factor (VEGFA), Complement Factor H (CFH), and LOC387715 genes could predict outcome to anti-VEGF therapy for patients with age related macular degeneration (AMD). METHODS: Patients with “wet” AMD...
Autores principales: | Kitchens, John W, Kassem, Nawal, Wood, William, Stone, Thomas W, Isernhagen, Rick, Wood, Edward, Hancock, Brad A, Radovich, Milan, Waymire, Josh, Li, Lang, Schneider, Bryan P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797648/ https://www.ncbi.nlm.nih.gov/pubmed/24143065 http://dx.doi.org/10.2147/OPTH.S39635 |
Ejemplares similares
-
Pharmacogenetics and Age-Related Macular Degeneration
por: Schwartz, Stephen G., et al.
Publicado: (2011) -
Pharmacogenetics and nutritional supplementation in age-related macular degeneration
por: Hampton, Blake M, et al.
Publicado: (2015) -
Recent advances and future directions for the pharmacogenetic basis of anti-VEGF treatment response in neovascular age-related macular degeneration
por: Riaz, Moeen, et al.
Publicado: (2017) -
Exploring the role of VEGF in Indian Age related macular degeneration
por: Sharma, Kaushal, et al.
Publicado: (2015) -
Complete RPE and outer retinal atrophy in patients receiving anti-VEGF treatment for neovascular age-related macular degeneration
por: Eng, Victor A., et al.
Publicado: (2020)